Safe with Proper Guidance: While generally safe for most users, individualized dosing and professional oversight are crucial to optimize its effects and mitigate potential risks, such as irritation at the injection site
We ask that if you've had a full panel blood work within the last 6 months to please bring in a physical copy to your appointment or email it over prior to [email protected]
Using the FAERS database from the second quater (Q2) of 2005 to the third quater (Q3) of 2024, we conducted a comprehensive analysis to investigate the association between GLP-1 RAs and NAEs
By 12 to 36 months after surgery, among patients with diabetes, 45.8 percent in the RYGB group and 61.4 percent in the SG group resumed taking GLP-1 RAs
In 2023, during Bidens Presidency, the Food and Drug Administration placed nineteen peptides, including BPC-157, on a do not compound list, citing potential significant safety risks that included immune reactions, pancreatitis, and accelerated growth of cancerous cells